RU2013104989A - Элемент днк, обладающий активностью, направленной на усиление экспрессии чужеродного гена - Google Patents

Элемент днк, обладающий активностью, направленной на усиление экспрессии чужеродного гена Download PDF

Info

Publication number
RU2013104989A
RU2013104989A RU2013104989/10A RU2013104989A RU2013104989A RU 2013104989 A RU2013104989 A RU 2013104989A RU 2013104989/10 A RU2013104989/10 A RU 2013104989/10A RU 2013104989 A RU2013104989 A RU 2013104989A RU 2013104989 A RU2013104989 A RU 2013104989A
Authority
RU
Russia
Prior art keywords
sequence
polynucleotide
foreign gene
seq
homologous
Prior art date
Application number
RU2013104989/10A
Other languages
English (en)
Russian (ru)
Inventor
Дайсуке НИСИМИЯ
Тацуя ИНОУЕ
Original Assignee
Дайити Санкио Компани, Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дайити Санкио Компани, Лимитед filed Critical Дайити Санкио Компани, Лимитед
Publication of RU2013104989A publication Critical patent/RU2013104989A/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/51—Complete heavy chain or Fd fragment, i.e. VH + CH1
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/515—Complete light chain, i.e. VL + CL
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/106—Plasmid DNA for vertebrates
    • C12N2800/107—Plasmid DNA for vertebrates for mammalian
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/46—Vector systems having a special element relevant for transcription elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU2013104989/10A 2010-07-07 2011-07-06 Элемент днк, обладающий активностью, направленной на усиление экспрессии чужеродного гена RU2013104989A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2010154782 2010-07-07
JP2010-154782 2010-07-07
PCT/JP2011/065916 WO2012005378A2 (en) 2010-07-07 2011-07-06 Dna element having the activity of enhancing foreign gene expression

Publications (1)

Publication Number Publication Date
RU2013104989A true RU2013104989A (ru) 2014-08-20

Family

ID=44630215

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2013104989/10A RU2013104989A (ru) 2010-07-07 2011-07-06 Элемент днк, обладающий активностью, направленной на усиление экспрессии чужеродного гена

Country Status (14)

Country Link
US (3) US9371543B2 (enExample)
EP (3) EP2591113B1 (enExample)
JP (2) JP5859988B2 (enExample)
KR (3) KR101856927B1 (enExample)
CN (3) CN103080321A (enExample)
AU (3) AU2011274864B2 (enExample)
BR (1) BR112012033780A2 (enExample)
CA (2) CA2916937A1 (enExample)
ES (3) ES2565428T3 (enExample)
IL (1) IL243763A0 (enExample)
RU (1) RU2013104989A (enExample)
SG (4) SG10201705118RA (enExample)
TW (2) TW201604280A (enExample)
WO (1) WO2012005378A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2591113B1 (en) * 2010-07-07 2016-01-20 Daiichi Sankyo Company, Limited Dna element having the activity of enhancing foreign gene expression
CN104066839B (zh) * 2011-11-28 2018-02-16 第一三共株式会社 衍生自人基因的启动子
JP7382138B2 (ja) * 2016-10-03 2023-11-16 第一三共株式会社 Hspa5遺伝子のプロモーター
CN107881174B (zh) * 2017-11-22 2022-06-03 张宝会 一种翻译水平基因表达调控的方法及应用
WO2020034097A1 (en) * 2018-08-14 2020-02-20 Wuxi Biologics (Shanghai) Co., Ltd. Transcriptional regulatory element and its use in enhancing the expression of exogenous protein
US20230192893A1 (en) * 2020-05-11 2023-06-22 Samsung Bioepis Co., Ltd. Human genome-derived polynucleotide and method for producing polypeptide of interest using same
WO2023210607A1 (ja) 2022-04-26 2023-11-02 第一三共株式会社 Eno1遺伝子のプロモーター

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU611263B2 (en) * 1988-02-12 1991-06-06 Commonwealth Scientific And Industrial Research Organisation Pox virus vectors
US20070161003A1 (en) * 2003-09-29 2007-07-12 Morris David W Novel therapeutic targets in cancer
EP2105742A1 (en) * 2008-03-26 2009-09-30 Sanofi-Aventis Use of cathepsin C
JP5344682B2 (ja) * 2008-12-26 2013-11-20 グローブライド株式会社 釣糸ガイド、及び釣糸ガイドの製造方法
EP2591113B1 (en) * 2010-07-07 2016-01-20 Daiichi Sankyo Company, Limited Dna element having the activity of enhancing foreign gene expression
CN104066839B (zh) * 2011-11-28 2018-02-16 第一三共株式会社 衍生自人基因的启动子

Also Published As

Publication number Publication date
US20160333371A1 (en) 2016-11-17
US10407694B2 (en) 2019-09-10
CN103865931B (zh) 2018-10-02
KR101920187B1 (ko) 2018-11-19
US20130171694A1 (en) 2013-07-04
US11060108B2 (en) 2021-07-13
EP3026117B1 (en) 2018-09-12
KR101856927B1 (ko) 2018-05-10
JP2013531967A (ja) 2013-08-15
TW201604280A (zh) 2016-02-01
CA2916937A1 (en) 2012-01-12
CN105950621B (zh) 2019-07-30
SG10201705118RA (en) 2017-07-28
AU2018200686A1 (en) 2018-02-22
AU2011274864B2 (en) 2016-10-06
WO2012005378A3 (en) 2012-04-12
CN103865931A (zh) 2014-06-18
CN105950621A (zh) 2016-09-21
JP2016054741A (ja) 2016-04-21
WO2012005378A2 (en) 2012-01-12
IL243763A0 (en) 2016-04-21
JP5859988B2 (ja) 2016-02-16
KR20180021246A (ko) 2018-02-28
CN103080321A (zh) 2013-05-01
US20190345515A1 (en) 2019-11-14
AU2011274864A1 (en) 2013-02-07
ES2565428T3 (es) 2016-04-04
CA2804381A1 (en) 2012-01-12
TWI507523B (zh) 2015-11-11
SG10201505354PA (en) 2015-08-28
EP2684961A1 (en) 2014-01-15
KR20130111514A (ko) 2013-10-10
JP6039048B2 (ja) 2016-12-07
KR20180021247A (ko) 2018-02-28
EP3026117A1 (en) 2016-06-01
CA2804381C (en) 2016-03-22
AU2018200686B2 (en) 2020-02-13
KR101833570B1 (ko) 2018-03-02
BR112012033780A2 (pt) 2016-05-31
TW201207103A (en) 2012-02-16
EP2684961B1 (en) 2016-01-20
AU2016203681A1 (en) 2016-06-23
SG186788A1 (en) 2013-02-28
ES2564227T3 (es) 2016-03-21
EP2591113B1 (en) 2016-01-20
ES2701091T3 (es) 2019-02-20
SG2014009187A (en) 2014-04-28
US9371543B2 (en) 2016-06-21
AU2016203681B2 (en) 2018-04-19
EP2591113A2 (en) 2013-05-15

Similar Documents

Publication Publication Date Title
RU2020103811A (ru) Гуманизированные животные по с5 и с3
EA201300054A1 (ru) Полипептид, обладающий активностью бета-глюкозидазы, и его применение
MX2021012595A (es) Polinucleotidos y polipeptidos aislados, sus metodos de utilizacion para mejorar la eficacia en el uso del nitrogeno, rendimiento, tasa de crecimiento, vigor, biomasa, contenido de aceite y/o tolerancia al estres abiotico.
EA201201126A1 (ru) Полипептид, обладающий активностью целлобиогидролазы, и его применение
JP2012095670A5 (enExample)
EA201300060A1 (ru) Полипептид, обладающий или содействующий активности деградации углеводного материала, и его применение
EA201300058A1 (ru) Полипептид, обладающий бета-глюкозидазной активностью, и его применение
WO2009150222A3 (en) Improved protein expression system
EA201170947A1 (ru) Растения, имеющие улучшенные характеристики урожайности, и способ их получения
MX2011013339A (es) Polinucleotidos y polipeptidos aislados, y metodos para utilizarlos para mejorar la eficacia en el uso de nitrogeno, rendimiento, tasa de crecimiento, vigor, biomasa, contenido de aceite y/o tolerancia al estres abiotico.
WO2013049121A3 (en) Recombinant phage and methods
NZ616646A (en) Synthetic genes
NZ595476A (en) Plant snf1-related protein kinase gene
NZ612405A (en) Nucleic acid molecules that target the vacuolar atpase c subunit and confer resistance to coleopteran pests
JP2016501515A5 (enExample)
JP2013531967A5 (enExample)
RU2011142793A (ru) Полученная из микроорганизма протеаза усовершенствованного типа, обеспечивающая свертывание молока
EA201300057A1 (ru) Полипептид, обладающий углеводдеградирующей активностью, и его применения
RU2017134418A (ru) Выявление аффинно-зрелых человеческих антител
ATE546464T1 (de) Verfahren zur produktion von rekombinantem protein in cho-zellen
RU2014121383A (ru) Происходящий из гена человека промотор
EA201300059A1 (ru) Полипептид, обладающий активностью сволленина, и его применение
EA201291159A1 (ru) Растения рода brassica с измененным строением
WO2015077538A3 (en) Nucleotide sequence encoding homeobox-leucine zipper protein hat22 (hd-zip protein 22) from corchorus olitorius and corchorus capsularis and methods of use
WO2015077447A3 (en) Nucleotide sequence encoding wuschel-related homeobox4 (wox4) protein from corchorus olitorius and corchorus capsularis and methods of use for same

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20161121